Observations placeholder
Ultravist and Iopromide
Identifier
019905
Type of Spiritual Experience
Number of hallucinations: 11
Background
A description of the experience
Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use.
It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).
On Dec, 13, 2016 7,251 people reported to have side effects when taking Ultravist.
Among them, 4 people (0.06%) have Hallucination
On Dec, 24, 2016 1,345 people reported to have side effects when taking Ultravist 150. Among them, 2 people (0.15%) have Hallucination
On Jan, 08, 2017 2,779 people reported to have side effects when taking Ultravist 300. Among them, 2 people (0.07%) have Hallucination
On Jan, 08, 2017 1,333 people reported to have side effects when taking Ultravist 370. Among them, 3 people (0.23%) have Hallucination, Visual
Time on Ultravist when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 13, 2016: 6,523 people reported to have side effects when taking Ultravist. Among them, 52 people (0.80%) have Death.
Time on Ultravist when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Ultravist :
| Female | Male | |
| Death | 61.54% | 38.46% |
Age of people who have Death when taking Ultravist :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.00% | 4.35% | 6.52% | 17.39% | 17.39% | 54.35% |
Top conditions involved for these people :
- Computerised tomogram abdomen (15 people, 28.85%)
- Hepatic cirrhosis (3 people, 5.77%)
- Hepatic neoplasm malignant (3 people, 5.77%)
- Percutaneous coronary intervention (3 people, 5.77%)
- Computerised tomogram abnormal (2 people, 3.85%)
On Jan, 7, 2016: 1,416 people reported to have side effects when taking Ultravist 150. Among them, 13 people (0.92%) have Death.
Time on Ultravist 150 when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 28, 2016: 2,787 people reported to have side effects when taking Ultravist 300. Among them, 14 people (0.50%) have Death.
Time on Ultravist 300 when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 5, 2016: 1,299 people reported to have side effects when taking Ultravist 370. Among them, 20 people (1.54%) have Death.
Time on Ultravist 370 when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |